{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:34:58Z","timestamp":1790699698881,"version":"4.1.0"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>We studied the potential protective effects of 1,25-dihydroxyvitamin D3 (1,25 VD3) supplementation on liver damage induced by a choline-deficient (CD) diet in rats, where impaired liver function leads to decreased 25-hydroxyvitamin D3 levels, the precursor for the active 1,25 VD3. The CD diet reduced serum 25 VD3 levels and increased liver enzymes, indicative of liver damage. Conversely, 1,25 VD3 supplementation alleviated liver damage, reducing liver enzymes and improving histopathological features characteristic of non-alcoholic steatohepatitis (NASH). Oxidative stress and inflammation were mitigated by 1,25 VD3, as evidenced by decreased malondialdehyde and nuclear factor kappa B (NF-\u03baB) expression, and increased total antioxidant capacity (TAOC). 1,25 VD3 also enhanced fatty acid metabolism by increasing peroxisome proliferator-activated receptor alpha (PPAR\u03b1) and carnitine palmitoyltransferase-1 (CPT-1) expression, promoting lipid transport and oxidation. Additionally, 1,25 VD3 supplementation modulated inflammation by increasing PPAR\u03b3 expression, reducing NF-\u03baB expression, and decreasing pro-inflammatory cytokines (TNF-\u03b1, IL-1\u03b2). Anti-inflammatory cytokines (IL-10, IL-4) were increased, and macrophage polarization was shifted towards an anti-inflammatory M2 phenotype. Moreover, 1,25 VD3 upregulated CYP2J3, a cytochrome P450 epoxygenase that converts arachidonic acid to anti-inflammatory epoxyeicosatrienoic acids (EETs) and decreased soluble epoxide hydrolase activity, likely contributing to increased EET levels. Correlation studies revealed positive associations between 1,25 VD3 supplementation, CYP2J3 expression, EETs, as well as negative correlations with NF-\u03baB and TNF-\u03b1. PPAR\u03b1 expression positively correlated with TAOC and CPT-1, while PPAR\u03b3 expression negatively correlated with inflammatory markers. These findings demonstrate the therapeutic potential of 1,25 VD3 in alleviating NASH through regulation of fatty acid metabolism, inflammation, and oxidative stress.<\/jats:p>","DOI":"10.3389\/fendo.2025.1528768","type":"journal-article","created":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T05:20:41Z","timestamp":1742534441000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["1,25-dihydroxyvitamin D3 improves non-alcoholic steatohepatitis phenotype in a diet-induced rat model"],"prefix":"10.3389","volume":"16","author":[{"given":"Mei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Zhun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Hui","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Shu","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Chen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Yang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-Hu","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Mei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"Mafld: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/brv.12178","article-title":"De novo lipogenesis in the liver in health and disease: more than just a shunting yard for glucose","volume":"91","author":"Sanders","year":"2016","journal-title":"Biol Rev Camb Philos Soc"},{"key":"B3","doi-asserted-by":"publisher","first-page":"9142","DOI":"10.1038\/s41598-019-45161-8","article-title":"Vitamin D receptors (Vdr), hydroxylases cyp27b1 and cyp24a1 and retinoid-related orphan receptors (Ror) level in human uveal tract and ocular melanoma with different melanization levels","volume":"9","author":"Markiewicz","year":"2019","journal-title":"Sci Rep"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/nu7105392","article-title":"Mechanisms underlying the regulation of innate and adaptive immunity by vitamin D","volume":"7","author":"Wei","year":"2015","journal-title":"Nutrients"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2014.02.004","article-title":"Regulation of the human cathelicidin antimicrobial peptide gene by 1alpha,25-dihydroxyvitamin D3 in primary immune cells","volume":"143","author":"Lowry","year":"2014","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1016\/j.clnu.2020.11.037","article-title":"A randomized controlled clinical trial comparing calcitriol versus cholecalciferol supplementation to reduce insulin resistance in patients with non-alcoholic fatty liver disease","volume":"40","author":"Mahmoudi","year":"2021","journal-title":"Clin Nutr"},{"key":"B7","first-page":"44","article-title":"Efficacy of vitamin D supplementation on adult patients with non-alcoholic fatty liver disease: A single-center experience","volume":"14","author":"Gad","year":"2021","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14129","article-title":"Vitamin D for treatment of non-alcoholic fatty liver disease detected by transient elastography: A randomized, double-blind, placebo-controlled trial","volume":"22","author":"Lukenda Zanko","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.5223\/pghn.2021.24.2.187","article-title":"Vitamin D effect on ultrasonography and laboratory indices and biochemical indicators in the blood: an interventional study on 12 to 18-year-old children with fatty liver","volume":"24","author":"Namakin","year":"2021","journal-title":"Pediatr Gastroenterol Hepatol Nutr"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.plefa.2020.102229","article-title":"Regulation of the cytochrome P450 epoxyeicosanoid pathway is associated with distinct histologic features in pediatric non-alcoholic fatty liver disease","volume":"164","author":"Kalveram","year":"2021","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s00394-016-1360-4","article-title":"Calcium and vitamin D(3) combinations improve fatty liver disease through ampk-independent mechanisms","volume":"57","author":"Shojaei Zarghani","year":"2018","journal-title":"Eur J Nutr"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2015.02.011","article-title":"A role of 1,25(Oh)2d3 supplementation in rats with nonalcoholic steatohepatitis induced by choline-deficient diet","volume":"25","author":"Han","year":"2015","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/biom10081133","article-title":"Arachidonic acid as an early indicator of inflammation during non-alcoholic fatty liver disease development","volume":"10","author":"Sztolsztener","year":"2020","journal-title":"Biomolecules"},{"key":"B14","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.prostaglandins.2016.07.002","article-title":"Characterization of the cytochrome P450 epoxyeicosanoid pathway in non-alcoholic steatohepatitis","volume":"125","author":"Wells","year":"2016","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1124\/mol.117.111047","article-title":"Effects of farnesoid X receptor activation on arachidonic acid metabolism, nf-kb signaling, and hepatic inflammation","volume":"94","author":"Gai","year":"2018","journal-title":"Mol Pharmacol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0110162","article-title":"The cytochrome P450 epoxygenase pathway regulates the hepatic inflammatory response in fatty liver disease","volume":"9","author":"Schuck","year":"2014","journal-title":"PloS One"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.R800038-JLR200","article-title":"Arachidonic acid cytochrome P450 epoxygenase pathway","volume":"50","author":"Spector","year":"2009","journal-title":"J Lipid Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2020.00451","article-title":"The anti-inflammatory effect of soluble epoxide hydrolase inhibitor and 14, 15-eet in kawasaki disease through ppargamma\/stat1 signaling pathway","volume":"8","author":"Dai","year":"2020","journal-title":"Front Pediatr"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2019.09.124","article-title":"Epoxyeicosatrienoic acids protect pancreatic beta cells against pro-inflammatory cytokine toxicity","volume":"520","author":"Grimes","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"B20","doi-asserted-by":"publisher","first-page":"16555","DOI":"10.1038\/s41598-021-96014-2","article-title":"Tppu treatment of burned mice dampens inflammation and generation of bioactive dhet which impairs neutrophil function","volume":"11","author":"Bergmann","year":"2021","journal-title":"Sci Rep"},{"key":"B21","doi-asserted-by":"publisher","first-page":"C996","DOI":"10.1152\/ajpcell.00402.2006","article-title":"Action of epoxyeicosatrienoic acids on cellular function","volume":"292","author":"Spector","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.106.013839","article-title":"Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated receptor alpha","volume":"35","author":"Ng","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s12272-012-0715-5","article-title":"Protective effects of gypenosides against fatty liver disease induced by high fat and cholesterol diet and alcohol in rats","volume":"35","author":"Qin","year":"2012","journal-title":"Arch Pharm Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S115855","article-title":"Diabetes and dyslipidemia: characterizing lipoprotein metabolism","volume":"10","author":"Tomkin","year":"2017","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/612089","article-title":"Peroxisome proliferator-activated receptor alpha target genes","volume":"2010","author":"Rakhshandehroo","year":"2010","journal-title":"PPAR Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"E97","DOI":"10.1152\/ajpendo.00366.2014","article-title":"Cyp2j2 overexpression attenuates nonalcoholic fatty liver disease induced by high-fat diet in mice","volume":"308","author":"Chen","year":"2015","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/sji.12791","article-title":"Epoxyeicosatrienoic acids alleviate methionine-choline-deficient diet-induced non-alcoholic steatohepatitis in mice","volume":"90","author":"Wang","year":"2019","journal-title":"Scand J Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11882-021-01022-x","article-title":"The role of ppar-gamma in allergic disease","volume":"21","author":"Stark","year":"2021","journal-title":"Curr Allergy Asthma Rep"},{"key":"B30","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.mce.2010.05.019","article-title":"Peroxisome proliferator activated receptor alpha (Pparalpha) and ppar gamma coactivator (Pgc-1alpha) induce carnitine palmitoyltransferase ia (Cpt-1a) via independent gene elements","volume":"325","author":"Song","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/srep44612","article-title":"Effect of modulation of ppar-gamma activity on kupffer cells M1\/M2 polarization in the development of non-alcoholic fatty liver disease","volume":"7","author":"Luo","year":"2017","journal-title":"Sci Rep"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0039165","article-title":"Inhibition of soluble epoxide hydrolase attenuates high-fat-diet-induced hepatic steatosis by reduced systemic inflammatory status in mice","volume":"7","author":"Liu","year":"2012","journal-title":"PloS One"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/nu11010077","article-title":"Beneficial effects of vitamin D treatment in an obese mouse model of non-alcoholic steatohepatitis","volume":"11","author":"Jahn","year":"2019","journal-title":"Nutrients"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2016.00498","article-title":"Vitamin D signaling through induction of paneth cell defensins maintains gut microbiota and improves metabolic disorders and hepatic steatosis in animal models","volume":"7","author":"Su","year":"2016","journal-title":"Front Physiol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.b20-00432","article-title":"A lipid-based nanocarrier containing active vitamin D(3) ameliorates nash in mice via direct and intestine-mediated effects on liver inflammation","volume":"43","author":"Mu","year":"2020","journal-title":"Biol Pharm Bull"},{"key":"B36","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.cbi.2018.04.010","article-title":"Vitamin D nanoemulsion enhances hepatoprotective effect of conventional vitamin D in rats fed with a high-fat diet","volume":"288","author":"El-Sherbiny","year":"2018","journal-title":"Chem Biol Interact"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/157834","article-title":"1,25-dihydroxyvitamin D(3) promotes high glucose-induced M1 macrophage switching to M2 via the vdr-ppargamma signaling pathway","volume":"2015","author":"Zhang","year":"2015","journal-title":"BioMed Res Int"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2019.1569298","article-title":"Vitamin D improves sunburns by increasing autophagy in M2 macrophages","volume":"15","author":"Das","year":"2019","journal-title":"Autophagy"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00148.2018","article-title":"Inhibition of soluble epoxide hydrolase ameliorates hyperhomocysteinemia-induced hepatic steatosis by enhancing beta-oxidation of fatty acid in mice","volume":"316","author":"Yao","year":"2019","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1146\/annurev-pharmtox-011112-140244","article-title":"Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health","volume":"53","author":"Morisseau","year":"2013","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"5838","DOI":"10.1038\/s41598-022-09618-7","article-title":"Oxylipin profile in saliva from patients with cystic fibrosis reveals a balance between pro-resolving and pro-inflammatory molecules","volume":"12","author":"Carnovale","year":"2022","journal-title":"Sci Rep"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-019-01780-2","article-title":"Circadian rhythms: A possible new player in non-alcoholic fatty liver disease pathophysiology","volume":"97","author":"Gnocchi","year":"2019","journal-title":"J Mol Med (Berl)"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3390\/cells12121582","article-title":"Circadian disruption primes myofibroblasts for accelerated activation as a mechanism underpinning fibrotic progression in non-alcoholic fatty liver disease","volume":"12","author":"Jokl","year":"2023","journal-title":"Cells"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3390\/biology4010104","article-title":"Lipids around the clock: focus on circadian rhythms and lipid metabolism","volume":"4","author":"Gnocchi","year":"2015","journal-title":"Biol (Basel)"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3390\/biology6010010","article-title":"Circadian rhythms and hormonal homeostasis: pathophysiological implications","volume":"6","author":"Gnocchi","year":"2017","journal-title":"Biol (Basel)"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3390\/nu16132111","article-title":"Association between serum vitamin D status and circadian syndrome: A cross-sectional study","volume":"16","author":"Arabi","year":"2024","journal-title":"Nutrients"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1177\/0748730414549239","article-title":"A role for 1alpha,25-dihydroxyvitamin D3 in the expression of circadian genes","volume":"29","author":"Gutierrez-Monreal","year":"2014","journal-title":"J Biol Rhythms"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1528768\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T05:20:45Z","timestamp":1742534445000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1528768\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,21]]},"references-count":47,"alternative-id":["10.3389\/fendo.2025.1528768"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1528768","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,21]]},"article-number":"1528768"}}